24 research outputs found
Different Conformations of Phosphatase and Tensin Homolog, Deleted on Chromosome 10 (PTEN) Protein within the Nucleus and Cytoplasm of Neurons
PTEN is a critical gene involved in the regulation of many cellular processes. The product of this gene has dual phosphatase activity and is able to dephosphorylate the 5′ end of the phosphatidylinositol (3,4,5)-trisphosphate. Within the cellular nucleus, this protein has been associated with regulation of the expression of many genes, although the mechanism of this regulation remains unclear. In this paper, two specific oligonucleotide aptamers were developed and selected, using the SELEX procedure, according to their ability to detect the PTEN protein in different subcellular compartments of neurons. While one aptamer was able to detect PTEN in the nucleus, the other recognized PTEN in the cytoplasm. The recognition pattern of PTEN by both aptamers was confirmed using antibodies in western blots of the proteins purified from mouse cerebellar homogenates and subcellular fractions. Additionally, we demonstrated that the two aptamers recognized different epitopes of the target peptide. The results presented here could not be fully explained by the canonical phosphatase structure of PTEN, suggesting the existence of different conformations of phosphatase in the nucleus and the cytoplasm
Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines
Temozolomide (TMZ) is the standard chemotherapeutic agent for human malignant glioma, but intrinsic or acquired chemoresistance represents a major obstacle to successful treatment of this highly lethal group of tumours. Obtaining better understanding of the molecular mechanisms underlying TMZ resistance in malignant glioma is important for the development of better treatment strategies. We have successfully established a passage control line (D54-C10) and resistant variants (D54-P5 and D54-P10) from the parental TMZ-sensitive malignant glioma cell line D54-C0. The resistant sub-cell lines showed alterations in cell morphology, enhanced cell adhesion, increased migration capacities, and cell cycle arrests. Proteomic analysis identified a set of proteins that showed gradual changes in expression according to their 50% inhibitory concentration (IC50). Successful validation was provided by transcript profiling in another malignant glioma cell line U87-MG and its resistant counterparts. Moreover, three of the identified proteins (vimentin, cathepsin D and prolyl 4-hydroxylase, beta polypeptide) were confirmed to be upregulated in high-grade glioma. Our data suggest that acquired TMZ resistance in human malignant glioma is associated with promotion of malignant phenotypes, and our reported molecular candidates may serve not only as markers of chemoresistance but also as potential therapeutic targets in the treatment of TMZ-resistant human malignant glioma, providing a platform for future investigations
The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma : a review focused on the genes' molecular mechanisms.
The malignant mesothelioma is an aggressive form
of cancer with a mean survival rate of less than a year.
Moreover, environmental exposure to minerals is an important
factor in the development of malignant mesothelioma (MM),
especially the mineral asbestos, which has a well-documented
role in MM, and more recently, the mineral erionite has been
proven to be a strong carcinogenic inducer of MM. In addition,
the virus simian virus 40 has been implicated as a cocarcinogenic
player in MM. However, the molecular mechanisms
involved in the pathogenesis of this cancer are still not
fully understood. Indeed, it is known that several genes are
altered ormutated inMM, among those are p16INK4A, p14ARF,
and neurofibromatosis type II. Furthermore, TP53 has been
reported to be mutated in the majority of the cancers; however,
inMM, it is very uncommon mutations in this gene. Also, the
PTEN gene has been shown to play an important role in
endometrial cancer and glioblastoma, although the role of
PTEN in MM has yet to be established. Taken altogether, this
review focuses on the historical aspects, molecular mechanisms,
interaction with other genes and proteins, and the role
of these genes inMM. Lastly, this review questions the cancer
theory of the two hits because the functions of both PTEN and
TP53 are not fully explained by this theory